Neurology
Nervous System Diseases
Psychiatry
Academies and Institutes
Neurosciences
Epilepsy
Headache
Neurologic Examination
Neuropsychiatry
Biography as Topic
Literature
Medicine in Literature
Brain Diseases
Conversion Disorder
Autoimmune Diseases of the Nervous System
Clinical Clerkship
Research Report
Headache Disorders
Neuropsychology
Neurosurgery
Stroke
Specialty Boards
Spasms, Infantile
Child Psychiatry
Hysteria
Referral and Consultation
Sleep Medicine Specialty
Parental Consent
Carcinoma, Lewis Lung
Copyright
Early theory and research on hemispheric specialization. (1/548)
This article provides an account of early theory and research on hemispheric specialization. It begins by tracing theory and research on localization of function that set the stage for the discovery of hemispheric specialization. After that, it describes the studies of Paul Broca, John Hughlings-Jackson, and others on hemisphere specialization and reviews some of the proposed explanations for the phenomenon. It then turns to the study of hemispheric specialization and mental illness, and it ends by identifying some of the linkages between theory and research from the past and the present. (+info)Measuring change in disability after inpatient rehabilitation: comparison of the responsiveness of the Barthel index and the Functional Independence Measure. (2/548)
BACKGROUND: The importance of evaluating disability outcome measures is well recognised. The Functional Independence Measure (FIM) was developed to be a more comprehensive and "sensitive" measure of disability than the Barthel Index (BI). Although the FIM is widely used and has been shown to be reliable and valid, there is limited information about its responsiveness, particularly in comparison with the BI. This study compares the appropriateness and responsiveness of these two disability measures in patients with multiple sclerosis and stroke. METHODS: Patients with multiple sclerosis (n=201) and poststroke (n=82) patients undergoing inpatient neurorehabilitation were studied. Admission and discharge scores were generated for the BI and the three scales of the FIM (total, motor, and cognitive). Appropriateness of the measures to the study samples was determined by examining score distributions, floor and ceiling effects. Responsiveness was determined using an effect size calculation. RESULTS: The BI, FIM total, and FIM motor scales show good variability and have small floor and ceiling effects in the study samples. The FIM cognitive scale showed a notable ceiling effect in patients with multiple sclerosis. Comparable effect sizes were found for the BI, and two FIM scales (total and motor) in both patients with multiple sclerosis and stroke patients. CONCLUSION: All measures were appropriate to the study sample. The FIM cognitive scale, however, has limited usefulness as an outcome measure in progressive multiple sclerosis. The BI, FIM total, and FIM motor scales show similar responsiveness, suggesting that both the FIM total and FIM motor scales have no advantage over the BI in evaluating change. (+info)The fate of neuroradiologic abstracts presented at national meetings in 1993: rate of subsequent publication in peer-reviewed, indexed journals. (3/548)
BACKGROUND AND PURPOSE: Abstract presentations are a valuable means of rapidly conveying new information; however, abstracts that fail to eventually become published are of little use to the general medical community. Our goals were to determine the publication rate of neuroradiologic papers originally presented at national meetings in 1993 and to assess publication rate as a function of neuroradiologic subspecialty and study design. METHODS: Proceedings from the 1993 ASNR and RSNA meetings were reviewed. A MEDLINE search encompassing 1993-1997 was performed cross-referencing lead author and at least one text word based on the abstract title. All ASNR and RSNA neuroradiologic abstracts were included. Study type, subspecialty classification, and sample size were tabulated. Publication rate, based on study design and neuroradiologic subspecialty, was compared with overall publication rate. Median duration from meeting presentation to publication was calculated, and the journals of publication were noted. RESULTS: Thirty-seven percent of ASNR abstracts and 33% of RSNA neuroradiologic abstracts were published as articles in indexed medical journals. Publication rates among neuroradiologic subspecialty types were not significantly different. Prospective studies presented at the ASNR were published at a higher rate than were retrospective studies. There was no difference between the publication rate of experimental versus clinical studies. Neuroradiologic abstracts were published less frequently than were abstracts within other medical specialties. Median time between abstract presentation and publication was 15 months. CONCLUSION: Approximately one third of neuroradiologic abstracts presented at national meetings in 1993 were published in indexed journals. This rate is lower than that of abstracts from medical specialties other than radiology. (+info)Specialty care for patients with epilepsy must become standard of care. Promotion of Specialty Care for Epilepsy Group. (4/548)
Epilepsy is a complex, common disorder with severe consequences for patients. The authors believe that a significant percentage of patients are receiving suboptimal care. The national standard of care needs to be upgraded to include the notion that patients with less than total seizure control or those suffering from any medication side-effects should be given the opportunity to receive specialty care by physicians with specific expertise in the field of epilepsy. (+info)Neurological disease, emotional disorder, and disability: they are related: a study of 300 consecutive new referrals to a neurology outpatient department. (5/548)
OBJECTIVES: To determine the prevalence of anxiety and depressive disorders in patients referred to general neurology outpatient clinics, to compare disability and number of somatic symptoms in patients with and without emotional disorder, the relation to neurological disease, and assess the need for psychiatric treatment as perceived by patients and doctors. METHODS: A prospective cohort study set in a regional neurology service in Edinburgh, Scotland. The subjects were 300 newly referred consecutive outpatients who were assessed for DSM IV anxiety and depressive disorders (PRIME-MD, and HAD), health status, and disability (SF-36), and patients', GPs' and neurologists' ratings of the need for patient to receive psychiatric or psychological treatment. RESULTS: Of 300 new patients, 140 (47%) met criteria for one or more DSM IV anxiety or depressive diagnosis. Major depression was the most common (27%). A comparison of patients with and without emotional disorder showed that physical function, physical role functioning, bodily pain, and social functioning were worse in patients with emotional disorders (p<0. 0005). The median number of somatic symptoms was greater in patients with emotional disorders (p<0.0005). These differences were independent of the presence of neurological disease. Few patients wished to receive psychiatric or psychological treatments. Both general practitioners and neurologists were more likely to recommend psychiatric treatment when the patients' symptoms were medically unexplained. CONCLUSIONS: Almost half of new referrals to general neurology clinics met criteria for a DSM IV psychiatric diagnosis. These patients were more disabled, and had more somatic symptoms. They expressed little enthusiasm for receiving psychiatric treatment. (+info)Do medically unexplained symptoms matter? A prospective cohort study of 300 new referrals to neurology outpatient clinics. (6/548)
OBJECTIVES: To determine (a) the proportion of patients referred to general neurology outpatient clinics whose symptoms are medically unexplained; (b) why they were referred; (c) health status and emotional disorder in this group compared with patients whose symptoms are explained by "organic" neurological disease. METHODS: The prospective cohort study with case note follow up at 6 months was carried out in the regional neurology service in Lothian, Scotland with 300 newly referred outpatients. Neurologists rated the degree to which patients' symptoms were explained by organic disease (organicity), GPs' reasons for referral, health status (SF-36), anxiety, and depressive disorders (PRIME-MD), RESULTS: Of 300 new patients 11% (95% confidence interval (95% CI) 7%-14%) had symptoms that were rated as "not at all explained" by organic disease, 19% (15% to 23%) "somewhat explained", 27% (22% to 32%) "largely explained", and 43% (37% to 49%) "completely explained" by organic disease. Reason for referral was not associated with "organicity". Comparison of these groups showed that although physical function was similar, the median number of physical symptoms and pain were greater in patients with lower organicity ratings (p<0.0005, p<0. 0005). Depressive and anxiety disorders were more common in patients with symptoms of lower organicity (70% of patients in the not at all group had an anxiety or depressive disorder compared with 32% in the completely explained group (p<0.0005). CONCLUSION: One third of new referrals to general neurology clinics have symptoms that are poorly explained by identifiable organic disease. These patients were disabled and distressed. They deserve more attention. (+info)An integrative approach to neurotoxicology. (7/548)
Exposure of human populations to a wide variety of chemicals has generated concern about the potential neurotoxicity of new and existing chemicals. Experimental studies conducted in laboratory animals remain critical to the study of neurotoxicity. An integrative approach using pharmacokinetic, neuropathological, neurochemical, electrophysiological, and behavioral methods is needed to determine whether a chemical is neurotoxic. There are a number of factors that can affect the outcome of a neurotoxicity study, including the choice of animal species, dose and dosage regimen, route of administration, and the intrinsic sensitivity of the nervous system to the test chemical. The neurotoxicity of a chemical can vary at different stages of brain development and maturity. Evidence of neurotoxicity may be highly subjective and species specific and can be complicated by the presence of systemic disease. The aim of this paper is to give an overview of these and other factors involved in the assessment of the neurotoxic potential for chemicals. This article discusses the neurotoxicity of several neurotoxicants (eg, acrylamide, trimethyltin, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, manganese, and ivermectin), thereby highlighting a multidisciplinary approach to the assessment of chemically induced neurotoxicity in animals. These model chemicals produce a broad range of effects that includes peripheral axonopathy, selective neuronal damage within the nervous system, and impaired neuronal-glial metabolism. (+info)Racial variation in treatment for transient ischemic attacks: impact of participation by neurologists. (8/548)
OBJECTIVE: This study evaluates the role of neurologists in explaining African American-white differences in the use of diagnostic and therapeutic services for cerebrovascular disease. DATA SOURCES/STUDY SETTING: Medicare inpatient hospital records were used to identify a random 20 percent sample of patients age 65 and over hospitalized with a principal diagnosis of TIA between January 1, 1991 and November 30, 1991 (n = 17,437). STUDY DESIGN: Medicare administrative data were used to identify five outcome measures: noninvasive cerebrovascular tests, cerebral angiography, carotid endarterectomy, anticoagulant therapy (as proxied by outpatient prothrombin time tests), and the specialty of the attending physician (neurologist versus other specialist). DATA COLLECTION/EXTRACTION METHODS: All Medicare claims were extracted for a 30-day period beginning with the date of admission. PRINCIPAL FINDINGS: Even after adjusting for patient demographics, comorbidity, ability to pay, and provider characteristics, African American patients were significantly less likely to receive noninvasive cerebrovascular testing, cerebral angiography, or carotid endarterectomy, compared with white patients, and to have a neurologist as their attending physician. At the same time, patients treated by neurologists were more likely to undergo diagnostic testing and less likely to undergo carotid endarterectomy. CONCLUSIONS: The findings suggest that African American patients with TIA may have less access to services for cerebrovascular disease and that at least some of this may be attributed to less access to neurologists. More research is needed on how patients at risk for stroke are referred to specialists. (+info)Examples of Nervous System Diseases include:
1. Alzheimer's disease: A progressive neurological disorder that affects memory and cognitive function.
2. Parkinson's disease: A degenerative disorder that affects movement, balance and coordination.
3. Multiple sclerosis: An autoimmune disease that affects the protective covering of nerve fibers.
4. Stroke: A condition where blood flow to the brain is interrupted, leading to brain cell death.
5. Brain tumors: Abnormal growth of tissue in the brain.
6. Neuropathy: Damage to peripheral nerves that can cause pain, numbness and weakness in hands and feet.
7. Epilepsy: A disorder characterized by recurrent seizures.
8. Motor neuron disease: Diseases that affect the nerve cells responsible for controlling voluntary muscle movement.
9. Chronic pain syndrome: Persistent pain that lasts more than 3 months.
10. Neurodevelopmental disorders: Conditions such as autism, ADHD and learning disabilities that affect the development of the brain and nervous system.
These diseases can be caused by a variety of factors such as genetics, infections, injuries, toxins and ageing. Treatment options for Nervous System Diseases range from medications, surgery, rehabilitation therapy to lifestyle changes.
There are many different types of epilepsy, each with its own unique set of symptoms and characteristics. Some common forms of epilepsy include:
1. Generalized Epilepsy: This type of epilepsy affects both sides of the brain and can cause a range of seizure types, including absence seizures, tonic-clonic seizures, and atypical absence seizures.
2. Focal Epilepsy: This type of epilepsy affects only one part of the brain and can cause seizures that are localized to that area. There are several subtypes of focal epilepsy, including partial seizures with complex symptoms and simple partial seizures.
3. Tonic-Clonic Epilepsy: This type of epilepsy is also known as grand mal seizures and can cause a loss of consciousness, convulsions, and muscle stiffness.
4. Lennox-Gastaut Syndrome: This is a rare and severe form of epilepsy that typically develops in early childhood and can cause multiple types of seizures, including tonic, atonic, and myoclonic seizures.
5. Dravet Syndrome: This is a rare genetic form of epilepsy that typically develops in infancy and can cause severe, frequent seizures.
6. Rubinstein-Taybi Syndrome: This is a rare genetic disorder that can cause intellectual disability, developmental delays, and various types of seizures.
7. Other forms of epilepsy include Absence Epilepsy, Myoclonic Epilepsy, and Atonic Epilepsy.
The symptoms of epilepsy can vary widely depending on the type of seizure disorder and the individual affected. Some common symptoms of epilepsy include:
1. Seizures: This is the most obvious symptom of epilepsy and can range from mild to severe.
2. Loss of consciousness: Some people with epilepsy may experience a loss of consciousness during a seizure, while others may remain aware of their surroundings.
3. Confusion and disorientation: After a seizure, some people with epilepsy may feel confused and disoriented.
4. Memory loss: Seizures can cause short-term or long-term memory loss.
5. Fatigue: Epilepsy can cause extreme fatigue, both during and after a seizure.
6. Emotional changes: Some people with epilepsy may experience emotional changes, such as anxiety, depression, or mood swings.
7. Cognitive changes: Epilepsy can affect cognitive function, including attention, memory, and learning.
8. Sleep disturbances: Some people with epilepsy may experience sleep disturbances, such as insomnia or sleepiness.
9. Physical symptoms: Depending on the type of seizure, people with epilepsy may experience physical symptoms such as muscle weakness, numbness or tingling, and sensory changes.
10. Social isolation: Epilepsy can cause social isolation due to fear of having a seizure in public or stigma associated with the condition.
It's important to note that not everyone with epilepsy will experience all of these symptoms, and some people may have different symptoms depending on the type of seizure they experience. Additionally, some people with epilepsy may experience additional symptoms not listed here.
There are several types of headaches, including:
1. Tension headache: This is the most common type of headache and is caused by muscle tension in the neck and scalp.
2. Migraine: This is a severe headache that can cause nausea, vomiting, and sensitivity to light and sound.
3. Sinus headache: This type of headache is caused by inflammation or infection in the sinuses.
4. Cluster headache: This is a rare type of headache that occurs in clusters or cycles and can be very painful.
5. Rebound headache: This type of headache is caused by overuse of pain medication.
Headaches can be treated with a variety of methods, such as:
1. Over-the-counter pain medications, such as acetaminophen or ibuprofen.
2. Prescription medications, such as triptans or ergots, for migraines and other severe headaches.
3. Lifestyle changes, such as stress reduction techniques, regular exercise, and a healthy diet.
4. Alternative therapies, such as acupuncture or massage, which can help relieve tension and pain.
5. Addressing underlying causes, such as sinus infections or allergies, that may be contributing to the headaches.
It is important to seek medical attention if a headache is severe, persistent, or accompanied by other symptoms such as fever, confusion, or weakness. A healthcare professional can diagnose the cause of the headache and recommend appropriate treatment.
Some common types of brain diseases include:
1. Neurodegenerative diseases: These are progressive conditions that damage or kill brain cells over time, leading to memory loss, cognitive decline, and movement disorders. Examples include Alzheimer's disease, Parkinson's disease, Huntington's disease, and amyotrophic lateral sclerosis (ALS).
2. Stroke: This occurs when blood flow to the brain is interrupted, leading to cell death and potential long-term disability.
3. Traumatic brain injury (TBI): This refers to any type of head injury that causes damage to the brain, such as concussions, contusions, or penetrating wounds.
4. Infections: Viral, bacterial, and fungal infections can all affect the brain, leading to a range of symptoms including fever, seizures, and meningitis.
5. Tumors: Brain tumors can be benign or malignant and can cause a variety of symptoms depending on their location and size.
6. Cerebrovascular diseases: These conditions affect the blood vessels of the brain, leading to conditions such as aneurysms, arteriovenous malformations (AVMs), and Moyamoya disease.
7. Neurodevelopmental disorders: These are conditions that affect the development of the brain and nervous system, such as autism spectrum disorder, ADHD, and intellectual disability.
8. Sleep disorders: Conditions such as insomnia, narcolepsy, and sleep apnea can all have a significant impact on brain function.
9. Psychiatric disorders: Mental health conditions such as depression, anxiety, and schizophrenia can affect the brain and its functioning.
10. Neurodegenerative with brain iron accumulation: Conditions such as Parkinson's disease, Alzheimer's disease, and Huntington's disease are characterized by the accumulation of abnormal proteins and other substances in the brain, leading to progressive loss of brain function over time.
It is important to note that this is not an exhaustive list and there may be other conditions or factors that can affect the brain and its functioning. Additionally, many of these conditions can have a significant impact on a person's quality of life, and it is important to seek medical attention if symptoms persist or worsen over time.
The diagnosis of conversion disorder is based on a combination of medical evaluation, psychiatric assessment, and ruling out other possible causes of the symptoms. Treatment typically involves a multidisciplinary approach, including psychotherapy, medication, and behavioral interventions. The goal of treatment is to address the underlying psychological issues and help individuals regain control over their physical symptoms.
Conversion disorder is a controversial diagnosis, with some experts arguing that it pathologizes normal human experiences and can be stigmatizing. Others argue that it is an important diagnostic category that helps to identify and treat individuals who are experiencing psychological distress that manifests as physical symptoms.
In recent years, there has been growing recognition of the importance of addressing the social and cultural factors that contribute to conversion disorder. Research has shown that individuals from marginalized communities and those who experience discrimination and trauma are more likely to experience conversion disorder. Therefore, it is important to approach treatment with a culturally sensitive and trauma-informed perspective.
In conclusion, conversion disorder is a complex and controversial diagnosis that requires a multidisciplinary approach to treatment. It is essential to consider the social and cultural factors that contribute to this condition and to approach treatment with sensitivity and compassion. By doing so, we can help individuals regain control over their physical symptoms and address the underlying psychological issues that are causing them distress.
Some common autoimmune diseases of the nervous system include:
1. Multiple sclerosis (MS): A chronic condition that affects the brain, spinal cord, and optic nerves, causing a range of symptoms including numbness, weakness, and vision problems.
2. Neuromyelitis optica (NMO): A rare condition that causes inflammation in the optic nerves and spinal cord, leading to vision loss and muscle weakness.
3. Guillain-Barré syndrome: A rare autoimmune disorder that causes muscle weakness and paralysis, often after a viral infection.
4. Chronic inflammatory demyelinating polyneuropathy (CIDP): A chronic condition that affects the peripheral nerves, causing numbness, weakness, and pain in the hands and feet.
5. Acute disseminated encephalomyelitis (ADEM): A rare condition that causes inflammation in the brain and spinal cord, leading to a range of symptoms including fever, headache, and muscle weakness.
The exact cause of autoimmune diseases of the nervous system is not fully understood, but they are believed to be triggered by a combination of genetic and environmental factors. Treatment options vary depending on the specific condition, but may include medications to reduce inflammation and modulate the immune system, as well as physical therapy and lifestyle modifications.
Primary headache disorders are those that are not caused by another medical condition or injury, and include:
1. Migraine: a severe, debilitating headache that can last for hours or even days, often accompanied by sensitivity to light and sound, nausea, and vomiting.
2. Tension headache: a common type of headache that is often described as a dull, squeezing pain on both sides of the head.
3. Cluster headache: a rare and intense form of headache that occurs in clusters or cycles, typically lasting several weeks or months.
4. Sinus headache: a type of headache caused by inflammation or infection in the sinuses.
5. Trigeminal neuralgia: a chronic pain disorder that affects the nerves in the face and head.
Secondary headache disorders are those that are caused by another medical condition or injury, such as:
1. Medication overuse headache: a type of headache that develops as a result of taking too much pain medication.
2. Hormonal headache: a type of headache that occurs due to changes in hormone levels, such as during menstruation or menopause.
3. Headache caused by underlying medical conditions, such as stroke, tumors, or sinusitis.
4. Headache caused by trauma or injury, such as whiplash or a concussion.
Headache disorders can have a significant impact on an individual's quality of life, and can affect their ability to work, sleep, and participate in daily activities. Treatment for headache disorders depends on the underlying cause, but may include medication, lifestyle changes, and alternative therapies such as acupuncture or biofeedback.
1. Ischemic stroke: This is the most common type of stroke, accounting for about 87% of all strokes. It occurs when a blood vessel in the brain becomes blocked, reducing blood flow to the brain.
2. Hemorrhagic stroke: This type of stroke occurs when a blood vessel in the brain ruptures, causing bleeding in the brain. High blood pressure, aneurysms, and blood vessel malformations can all cause hemorrhagic strokes.
3. Transient ischemic attack (TIA): Also known as a "mini-stroke," a TIA is a temporary interruption of blood flow to the brain that lasts for a short period of time, usually less than 24 hours. TIAs are often a warning sign for a future stroke and should be taken seriously.
Stroke can cause a wide range of symptoms depending on the location and severity of the damage to the brain. Some common symptoms include:
* Weakness or numbness in the face, arm, or leg
* Difficulty speaking or understanding speech
* Sudden vision loss or double vision
* Dizziness, loss of balance, or sudden falls
* Severe headache
* Confusion, disorientation, or difficulty with memory
Stroke is a leading cause of long-term disability and can have a significant impact on the quality of life for survivors. However, with prompt medical treatment and rehabilitation, many people are able to recover some or all of their lost functions and lead active lives.
The medical community has made significant progress in understanding stroke and developing effective treatments. Some of the most important advances include:
* Development of clot-busting drugs and mechanical thrombectomy devices to treat ischemic strokes
* Improved imaging techniques, such as CT and MRI scans, to diagnose stroke and determine its cause
* Advances in surgical techniques for hemorrhagic stroke
* Development of new medications to prevent blood clots and reduce the risk of stroke
Despite these advances, stroke remains a significant public health problem. According to the American Heart Association, stroke is the fifth leading cause of death in the United States and the leading cause of long-term disability. In 2017, there were over 795,000 strokes in the United States alone.
There are several risk factors for stroke that can be controlled or modified. These include:
* High blood pressure
* Diabetes mellitus
* High cholesterol levels
* Smoking
* Obesity
* Lack of physical activity
* Poor diet
In addition to these modifiable risk factors, there are also several non-modifiable risk factors for stroke, such as age (stroke risk increases with age), family history of stroke, and previous stroke or transient ischemic attack (TIA).
The medical community has made significant progress in understanding the causes and risk factors for stroke, as well as developing effective treatments and prevention strategies. However, more research is needed to improve outcomes for stroke survivors and reduce the overall burden of this disease.
Infantile spasms typically occur in children under the age of 2, with the peak incidence between 6-12 months. They are more common in boys than girls and can be associated with other conditions such as fragile X syndrome, tuberous sclerosis, and other genetic disorders.
The exact cause of infantile spasms is not fully understood, but they are believed to be related to abnormal electrical activity in the brain. Treatment options for infantile spasms include anticonvulsant medications such as adrenocorticotropic hormone (ACTH) and vigabatrin, as well as surgical interventions in some cases.
It is important to seek medical attention if your child exhibits signs of infantile spasms, as early diagnosis and treatment can improve outcomes and reduce the risk of long-term complications such as developmental delays and intellectual disability.
In the medical field, hysteria is not a recognized diagnosis in the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) or the International Classification of Diseases (ICD-10). Instead, symptoms that were previously described as hysteria are now classified under other diagnostic categories such as anxiety disorders, mood disorders, and somatic symptom disorder.
Hysteria is sometimes used as a colloquial term to describe extreme or irrational fears or phobias, but this usage is not considered a valid medical diagnosis. It's important to note that any persistent physical or psychological symptoms should be evaluated by a qualified healthcare professional for an accurate diagnosis and appropriate treatment.
The tumor cells are typically small, uniform, and well-differentiated, with a distinct cell border and a central nucleus. The tumor cells are often arranged in a glandular or tubular pattern, which is characteristic of this type of cancer.
Carcinoma, Lewis lung usually affects older adults, with the median age at diagnosis being around 60 years. Men are slightly more likely to be affected than women. The main risk factor for developing this type of cancer is smoking, although it can also occur in people who have never smoked.
The symptoms of Carcinoma, Lewis lung can vary depending on the location and size of the tumor, but they may include:
* Chest pain or discomfort
* Coughing up blood
* Shortness of breath
* Fatigue
* Weight loss
If you suspect you may have Carcinoma, Lewis lung or are experiencing any of these symptoms, it is important to consult a healthcare professional for an accurate diagnosis and appropriate treatment.
The post Definition of 'Carcinoma, Lewis Lung' in the medical field appeared first on Healthy Life Tips.
Neurology
JAMA Neurology
Extinction (neurology)
Behavioral neurology
Neurology (journal)
Neurology India
Psychon (neurology)
Restorative neurology
Geriatric neurology
Lancet Neurology
European Neurology
Pediatric Neurology
Experimental Neurology
Annals of Neurology
Surgical Neurology International
Journal of Neurology
Nature Reviews Neurology
American Academy of Neurology
European Journal of Neurology
Clinical Neurology and Neurosurgery
Journal of Child Neurology
Vitamin D and neurology
Cognitive and Behavioral Neurology
World Federation of Neurology
European Academy of Neurology
Developmental Medicine & Child Neurology
Romanian School of Neurology
Current Opinion in Neurology
History of neurology and neurosurgery
The Journal of Comparative Neurology
Efficacy and safety of eptinezumab in patients with chronic migraine: PROMISE-2 - PubMed
Four Major Neurology Updates
Top Neurology Studies to Know
Frances K. Conley, MD - surgery (neurology) | NLM)(example)
Focus on Neurology
Cluster Headache Guidelines: European Academy of Neurology
Studies in Neurology | The BMJ
Adult Neurology Clinics
PAR-03-174: PRELIMINARY INVESTIGATIONS LEADING TO OPTIMAL TRIALS IN NEUROLOGY
Neurology Today
Neurology Department - Submitter - ClinVar
NOT-NS-06-007: Clinical Trial Methods In Neurology
Frontiers in Neurology | Applied Neuroimaging
Department of Neurology - Submitter - ClinVar
Neurology / Neuroscience - May 29, 2018 Edition
Catherine Chu, MD - Department of Neurology
Neurology - Submitter - ClinVar
RUSH Neurology - Epilepsy | RUSH
Vascular Neurology Match | NRMP
American Academy of Neurology: Neurology Resources | AAN
Our Experts | Johns Hopkins Neurology and Neurosurgery
Child Neurology Residency | Medical College of Wisconsin
Join Us | Neurology & Neurological Sciences | Stanford Medicine
Department of Neurology - Medical School - UT Southwestern
American Academy o3
- These seemingly fantastic topics were the focus of the Hot Topics Plenary Session [ 1 ] at this year's American Academy of Neurology annual meeting. (medscape.com)
- People who eat a diet rich in vegetables, fruit, nuts and fish may have bigger brains, according to a study published in the May 16, 2018, online issue of Neurology, the medical journal of the American Academy of Neurology. (news-medical.net)
- Neurologists have identified a new type of vertigo with no known cause, according to a study published in the May 23, 2018, online issue of Neurology®, the medical journal of the American Academy of Neurology. (news-medical.net)
20202
- With the arrival in 2020 of our Chair, Dr. Elan Louis, we are home to Merritt's Textbook of Neurology, one of the premier and longest standing neurological textbooks in the country. (utsouthwestern.edu)
- This virtual event on Tuesday, September 1, 2020, introduced the neurology module of the "Bench to Bedside" course. (nih.gov)
Pediatric Neurology5
- NorthShore's Pediatric Neurology and Epilepsy program provides family-centered diagnosis and comprehensive care for children with disorders of the brain and nervous system. (northshore.org)
- Explore the NorthShore Pediatric Neurology and Epilepsy program with Dr. Takijah Heard, Dr. Margaret Michelson, and Dr. Leslie Finkel. (northshore.org)
- Before your appointment, we ask that you fill out and bring with you the general pediatric neurology intake questionnaire . (northshore.org)
- The Division of Pediatric Neurology evaluates and treats pediatric patients with disorders of the central and peripheral nervous systems, such as seizures and epilepsy, headache, neuromuscular disease and tics. (upmc.com)
- Contact the Division of Pediatric Neurology at 412-692-5520. (upmc.com)
Neurosurgery2
- UT Southwestern Medical Center is among the nation's top hospitals for neurology and neurosurgery, according to U.S. News & World Report . (utsouthwestern.edu)
- The Surgical Neurology Branch of NINDS offers a basic, translational and clinical research training program for surgeons committed to a career in academic neurosurgery. (nih.gov)
Subspecialty3
- Responsibilities will include care of general and subspecialty neurology patients, and teaching of medical students, residents and clinical fellows. (stanford.edu)
- Through this partnership, UTSW Neurologists with residents and fellows both serve and diffuse subspecialty Neurology expertise deeply through the fabric of our Dallas community. (utsouthwestern.edu)
- We take pride in bringing advanced neurological care that covers some 12,000 visits to Parkland Neurology Clinic per year, more than 14,000 patient-days across our 4 inpatient Neurology subspecialty services and 3,800 new emergency neurology or inpatient consults annually. (utsouthwestern.edu)
20232
- The European Academy of Neurology (EAN) published guidelines for the treatment of cluster headache in July 2023. (medscape.com)
- The Child Neurology Residency Program will be conducting virtual interviews for the 2022-2023 academic year. (mcw.edu)
Fellowship2
- The Surgical Neurology Branch offers a one or two-year research fellowship. (nih.gov)
- With a focus on clinical practice and research, the ACGME-accredited Vascular Neurology Fellowship at the NIH/NINDS Stroke Program is designed for neurologists who seek to become experts in the management of cerebrovascular disorders. (nih.gov)
Field of neurology1
- The editors have compiled the most pertinent articles to highlight a few that will be most useful for busy practitioners as well as researcher in the field of neurology. (nature.com)
NINDS2
- The purpose of the PRELIMINARY INVESTIGATIONS LEADING TO OPTIMAL TRIALS IN NEUROLOGY grant (for brevity referred to as NINDS Preliminary Clinical Trials grant) is to obtain preliminary data and conduct studies to support the rationale for a subsequent definitive clinical trial of an intervention to treat or prevent neurological disease. (nih.gov)
- The National Institute of Neurological Disorders and Stroke (NINDS) is considering issuing a contract to develop a course of intensive training in clinical trial methodology for neurology research. (nih.gov)
Faculty3
- Learn more about our child neurology faculty. (mcw.edu)
- The Department of Neurology and Neurological Sciences, School of Medicine, and Stanford University value faculty who are committed to advancing diversity, equity, and inclusion. (stanford.edu)
- The Brain and Behavior course, co-directed by faculty in Neurology, Psychiatry, and Neuropathology, is consistently in the top-rated pre-clinical medical student courses each year. (utsouthwestern.edu)
Neurologists3
- The Department of Neurology and Neurological Sciences at Stanford University School of Medicine is seeking board-eligible or board-certified neurologists to join the Department as a Clinical Assistant Professor, Clinical Associate Professor, or Clinical Professor in the Clinician Educator line. (stanford.edu)
- UT Southwestern's Department of Neurology is dedicated to excellent patient care, breakthrough research, and top-level education of future neurologists. (utsouthwestern.edu)
- The UT Southwestern Department of Neurology focuses on providing the highest level of neurological care for our patients, conducting innovative research, and training the next generation of neurologists. (utsouthwestern.edu)
Clinicians2
- Genetics in Medicine has published numerous articles of interest to clinicians working in neurology. (nature.com)
- Our goal is to train excellent vascular neurology clinicians, academicians, and researchers. (nih.gov)
Psychiatry1
- Additional information can be found through the Society of Vascular and Interventional Neurology and the American Board of Psychiatry and Neurology . (nrmp.org)
Movement Disorders1
- The clinical subspecialists of Virtua Neurology provide care for acute and chronic conditions, from migraine to memory loss to movement disorders. (virtua.org)
Vascular3
- Vascular Neurology focuses on selected neurological disorders involving the central nervous system, due to ischemic or hemorrhagic events or neurovascular disorders. (nrmp.org)
- This unique program design orients the Fellow to the role of vascular neurology in both academic and community hospital settings while providing access to greater diversity in disease etiology. (nih.gov)
- In addition to clinical rotations, vascular neurology fellows will participate in teaching and educational activities for medical students, residents, and other affiliated staff. (nih.gov)
Fellows1
- Neurology has a long-standing tradition of providing a dynamic, progressive and engaging learning environment for our students, residents, and fellows. (utsouthwestern.edu)
Neurological disorders1
- Virtua Neurology - Westampton is a practice of highly specialized physicians providing diagnosis and treatment for a wide range of complex neurological disorders affecting the brain, spinal cord and peripheral nerves. (virtua.org)
Medscape1
- Cite this: Four Major Neurology Updates - Medscape - May 20, 2016. (medscape.com)
Associate Professor2
- Dr. Chu is a board-certified child neurologist and neurophysiologist at Massachusetts General Hospital and Associate Professor of Neurology at Harvard Medical School. (massgeneral.org)
- The Department of Neurology & Neurological Sciences at Stanford University seeks a neuropsychologist as Professor, Associate Professor or Assistant Professor in the University Tenure Line (UTL) or University Medical Line (UML). (stanford.edu)
Department1
- The department is committed to expanding access to neurology care to communities outside of Pittsburgh. (upmc.com)
20182
- In 2018, he helped launch Zambia's first neurology research training program. (nih.gov)
- This has helped to spur the neurology training program we launched in Zambia in October 2018, which will put more boots on the ground and allow us to see the disease processes in various parts of the country. (nih.gov)
Login1
- We have changed the login procedure to improve access between AAN.com and the Neurology journals. (neurology.org)
20191
- In addition to providing consultative services at Clements University Hospital, UTSW Neurology cared for 1,539 inpatients in 2019. (utsouthwestern.edu)
Brain1
- An active Student Interest Group in Neurology (SIGN) hosts regular career talks and an annual Brain Awareness Week. (utsouthwestern.edu)
Researchers2
- The need for more medically-trained researchers with appropriate methodological training has been identified as an important limiting factor in the scope and quality of clinical research overall and specifically in neurology. (nih.gov)
- It is anticipated that this annual course will yield a group of talented, dedicated neurology researchers who will consequently be in a position to obtain funding for their own high quality clinical research. (nih.gov)
Dementia1
- The Cognitive and Behavioral Neurology Division specializes in care for patients with Alzheimer's disease, dementia, and other cognitive disorders. (upmc.com)
Center4
- Dr. Omar Siddiqi first visited Zambia in 2005 when he was a neurology resident at Beth Israel Deaconess Medical Center to explore the possibilities of doing global health neurology research there. (nih.gov)
- Siddiqi is an assistant professor of neurology at Harvard Medical School, the Director of the Global Neurology Program at Beth Israel Deaconess Medical Center , and a lecturer at the University of Zambia. (nih.gov)
- But my mentors - Dr. Gretchen Birbeck, who has been doing neurology research in Zambia since 2001, and Dr. Igor Koralnik, then the director of the HIV/Neurology Center at my home institution, Beth Israel Deaconess Medical Center - took me under their wings and gave me sound advice: Start by finding a research question you're interested in, that's relevant to the setting, and that you can carry through to completion. (nih.gov)
- The Surgical Neurology Branch laboratories and clinical facilities are located in the basic science facilities and Clinical Center on the NIH campus in Bethesda, Maryland. (nih.gov)
General1
- Contact the General Neurology Division at 412-692-4920. (upmc.com)
Hospital1
- Neurology Psychology Template - modern and colorful design that let you to build an awesome website for psychiatrists, medical consulting, mental counselors, psychologists, medical consultants, therapists, life coach, mental health care, private psychiatrist clinic and for any medical or hospital related websites. (themeforest.net)
Care1
- The Women's Neurology Division at UPMC specializes in understanding the health care needs of women with neurological conditions. (upmc.com)
Program3
- If the program is successful, it is anticipated that students will return to their academic departments where they will take a prominent role in advancing local research priorities in neurology. (nih.gov)
- Dr. Omar Siddiqi (right), who helped launch Zambia's first neurology research training program, discusses a patient's diagnosis with her family and a trainee. (nih.gov)
- MD or DO degree and successful completion of an ACGME accredited neurology residency training program. (nih.gov)
Services1
- The Neurology comes up with 3+ completely different pre-made homepages that have unlimited creativity in style and colors, flexible layouts and super powerful functionality for the services, teams, doctors, products, blog and different elements. (themeforest.net)
Team1
- A brief introduction to the team that leads the Child Neurology Residency. (mcw.edu)
Experts1
- Our neurology experts help patients manage these conditions during pregnancy and other life events. (upmc.com)
University1
- Eva Feldman, the Russell N. DeJong professor of neurology at the University of Michigan, spoke about her group's experience with spinal cord stem cell transplants for ALS. (medscape.com)